Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
04/12/1995 | EP0647277A1 Methods for using cks fusion proteins |
04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
04/12/1995 | EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
04/12/1995 | EP0357672B1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
04/11/1995 | US5405941 Gene therapy; anticancer, antiinflammatory agents, autoimmune diseases, Alzheimers*s |
04/11/1995 | US5405940 Isolated nonapeptides derived from MAGE genes and uses thereof |
04/11/1995 | US5405785 Derivatives of cyclosporine A, antibodies directed thereto and uses thereof |
04/11/1995 | US5405783 Removing photoremovable protective group from region of substrate, contacting with protected amino acid, repeating to form peptide |
04/11/1995 | US5405748 Purification of the Gal/GalNAc lectin from a nonpathogenic form of the parasite |
04/11/1995 | CA1335180C Anti-thrombin-binding substance monoclonal antibodies, hybridomas producing same, as well as purification process and assay of thrombin-binding substance making use of said monoclonal antibodies |
04/06/1995 | WO1995009232A2 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof |
04/06/1995 | WO1995009187A1 Monoclonal antibody and assay of denatured dna by using the same |
04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
04/06/1995 | WO1995009182A1 Protective antigens against parasites |
04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
04/06/1995 | WO1995007466A3 Biotin-analog conjugated antibodies for positive cell selection and release |
04/06/1995 | DE4042408C2 Compsns. for enhancing embryo prodn. in livestock |
04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
04/06/1995 | CA2172492A1 Protective antigens against parasites |
04/05/1995 | EP0646794A1 Method of immunological assaying of human osteocalcin, reagent and kit therefor, antibody to human osteocalcin, hybridoma producing said antibody, and method of producing it |
04/05/1995 | EP0646793A2 Methods for utilizing cell lines which lack human class II histocompatibility antigens |
04/05/1995 | EP0646600A1 A cell growth-inhibiting protein |
04/05/1995 | EP0646377A1 Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof |
04/05/1995 | EP0646244A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
04/05/1995 | EP0646174A1 Recombinant production of saporin-containing proteins |
04/05/1995 | EP0646173A1 Reagent for agglutination assays |
04/05/1995 | EP0646129A1 Receptor-type tyrosine kinase-like molecules |
04/05/1995 | EP0646014A1 The use of hyperimmune milk to increase longevity |
04/05/1995 | EP0646010A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression |
04/05/1995 | EP0646000A1 Compositions using microencapsulated neutralizing antibodies |
04/05/1995 | EP0507839B1 Method of separating haemopoietic progenitor cells |
04/05/1995 | EP0318554B1 Targeted multifunctional proteins |
04/05/1995 | EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
04/05/1995 | CN1028114C Monoclonal antibody specific for adhesion function domain of phagocyte surface protein |
04/04/1995 | US5403926 Hepatocellular carcinoma oncogene |
04/04/1995 | US5403924 Taga gene and methods for detecting predisposition to peptic ulceration |
04/04/1995 | US5403919 Monoclonal antibodies as inhibitors |
04/04/1995 | US5403914 Biological mediators of immune functions |
04/04/1995 | US5403718 Methods and antibodies for the immune capture and detection of Borrelia burgdorferi |
04/04/1995 | US5403716 Method for measurement of tissue factor in high sensitivity and measurement kit therefor |
04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
03/30/1995 | WO1995008771A1 Immobilization of chemically cross-linked proteins on solid supports |
03/30/1995 | WO1995008646A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | WO1995008628A2 Nucleic acids encoding merosin, merosin fragments and uses thereof |
03/30/1995 | WO1995008627A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
03/30/1995 | WO1995008577A1 Retargeting antibodies |
03/30/1995 | WO1995008576A1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors |
03/30/1995 | WO1995008575A1 Monoclonal antibodies specific for feline infectious peritonitis virus |
03/30/1995 | WO1995008572A1 Interaction of t-cell receptors and antigen in autoimmune disease |
03/30/1995 | WO1995008570A1 Chimeric proteins which block complement activation |
03/30/1995 | WO1995008569A1 NOVEL PROTEIN sp38 AND CONTRACEPTIVE VACCINE |
03/30/1995 | WO1995008566A1 Novel peptide |
03/30/1995 | WO1995008562A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
03/30/1995 | WO1995008336A1 Graves' ophthalmopathy associated antibodies, graves' ophthalmopathy orbital antigen, and methods of use thereof |
03/30/1995 | DE4332596A1 Monoclonal antibodies |
03/30/1995 | CA2172610A1 Chimeric proteins which block complement activation |
03/30/1995 | CA2172512A1 Interaction of t-cell receptors and antigen in autoimmune disease |
03/30/1995 | CA2172504A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
03/30/1995 | CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | CA2172385A1 Nucleic acids encoding merosin, merosin fragments and uses thereof |
03/30/1995 | CA2171607A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
03/30/1995 | CA2171206A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
03/30/1995 | CA2169620A1 Retargeting antibodies |
03/30/1995 | CA2150029A1 Immobilization of chemically cross-linked proteins on solid supports |
03/30/1995 | CA2149783A1 Novel peptides |
03/29/1995 | EP0645628A1 Immunological detection method of pyrethroid compound, haptenic compound, intermediate for the haptenic compound, immunogen and antibody |
03/29/1995 | EP0645450A1 Human calcitonin precursor polyprotein structural gene |
03/29/1995 | EP0645147A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
03/29/1995 | EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor |
03/29/1995 | EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
03/29/1995 | EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
03/29/1995 | EP0644930A1 Monoclonal antibody against the extra-villous trophoblast |
03/29/1995 | EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses |
03/29/1995 | EP0644896A1 PEPTIDES REPRESENTING ANTIGENIC EPITOPES OF IgE PRESENT ON B CELL BUT NOT BASOPHIL SURFACE |
03/29/1995 | EP0644895A1 Active component of parathyroid hypertensive factor |
03/29/1995 | EP0644884A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels |
03/29/1995 | EP0644768A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation |
03/29/1995 | EP0563144B1 Diagnosis for porcine malignant hyperthermia |
03/29/1995 | EP0460190B1 Method for detecting malignant diseases |
03/29/1995 | EP0403558B1 Antibodies for use in antilymphocyte antibody therapy |
03/29/1995 | EP0393045B1 Fv antibody fragment production |
03/29/1995 | CN1100656A Improved meningococcal polysaccharide conjugate vaccine |
03/28/1995 | US5401831 Monoclonal antibodies for differentiating pathogenic and nonpathogenic E. histolytica |
03/28/1995 | US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment |
03/28/1995 | US5401656 Screening for Rocky Mountain spotted fever and ehrlichiosis |
03/28/1995 | US5401652 Nucleic acid sequence encoding apamin receptor protein |
03/28/1995 | US5401638 Detection and quantification of neu related proteins in the biological fluids of humans |
03/28/1995 | US5401635 Nucleic acids encoding human prohibitin mutants and detection thereof |
03/28/1995 | US5401634 Stable biologically active fluorochemical emulsions |
03/28/1995 | US5401628 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
03/28/1995 | US5401627 Warts, cancer |
03/28/1995 | CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response |
03/28/1995 | CA2012631C Process for the production of hetero-bispecific antibodies |
03/28/1995 | CA1334942C Production of m-csf |
03/28/1995 | CA1334941C Cloning and expression of a host-protective immunogens of ibdv |